voclosporinlupus nephritisprednisoloneKDIGO 2024
…jectives Following the successful AURORA-1 and AURORA-2 trials, voclosporin was incorporated into the KDIGO 2024 clinical guidelines for th…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 327 of 245993.3%
systemic lupus erythematosusSLEself-management education
…ement education is a foundational component in the treatment of systemic lupus erythematosus (SLE), promoting the achievement of therapeutic goals and enabl…
dapagliflozindapagliflozin-associatedlupus nephritisDapagliflozin-treatedSLEsystemic lupus erythematosus
… phenotypes and to explore potential immunometabolic effects of dapagliflozin in lupus nephritis.Methods Thirty-six female SLE patients were …
RituximabSLEhydroxychloroquineBelimumabAnifrolumabdiabetes mellitusosteoporosis with fracturecataractarterial hypertensioncardiovascular events
…pressant, 36 (13.3%) Belimumab, 14 (5.2%) Anifrolumab, 4 (1.5%) Rituximab, and only 46 (17%) glucocorticoids, of whom 80.4% were on doses…
SLELegendplexfunisitis
…lance of the pro- and antiangiogenic factors S-Flt1/PlGF during SLE pregnancy resulting in SGA.…
lupus arthritisSLEglucocorticoid therapyVisual Analogue ScaleLAMDArheumatoid arthritisLAMDA28
… clinical disease activity measure to improve the assessment of lupus arthritis. Further validation is underway in multinational RCTs. LAMDA wa…
lupus nephritisimmunosuppressant therapysuPARKarolinska University hospitalNIHLN
…tudy, we aimed to investigate serum suPAR levels in relation to lupus nephritis (LN), including activity and chronicity features in diagnostic …
Pancreatic exocrine insufficiencyneuroendocrine tumoursPRRToxalate nephropathypeptide receptor radionuclide therapysmall bowel NETsomatostatin analogue therapypancreatic enzyme replacement therapyPEIsecretory NET+1 more
…Pancreatic exocrine insufficiency (PEI) is an under-recognised cause of chronic diarrhoea in pati…
sugemalimabadvanced oesophageal squamous-cell carcinoma (ESCC)ESCC
…tively.Conclusion From a Chinese healthcare system perspective, sugemalimab plus chemotherapy as first-line treatment for advanced ESCC mig…
eye diseasecancerNational Institute for Health and Care ExcellenceNICE
…ange (IQR) 4.5-14.75) in contrast with guidelines on cancer and eye disease covering the fewest conditions (median 3, 1-4.5; median 3, 2.25…
patiromerHyperkalaemiaHKalbuterolNCT04443608
…e, 5 units intravenous insulin and 10 mg albuterol) with either patiromer or placebo. The initial dose was given within 1 hour of the pot…
Parkinson’s diseaseoccupation-focused complex interventionPDnon-pharmacological treatmentsParkinson
…Background Anxiety is a common non-motor symptom of Parkinson’s disease (PD). There is no specific pharmacological intervention for peo…